Atlas Trials

Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Clinical trial NCT07174349 · RECRUITING

Trial details

NCT number
NCT07174349
Sponsor
Mayo Clinic
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Urinary Retention Postoperative
Start date
2026-10-01
Primary completion
2027-01-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.